Zai Lab ZLAB
NASDAQ ZLAB
$26.28 -0.72 (-2.67%)
As of: Sep 4, 2026 · 3:18 PM EDT

Zai Lab (ZLAB) Depreciation & Amortization (CF) (2018 - 2026)

Zai Lab (ZLAB) posted Depreciation & Amortization (CF) of $3.9 million for Q1 2026, up 0.72% sequentially from $3.9 million in Q4 2025, and up 14.05% YoY from $3.5 million in Q1 2025.

Analysis

Zai Lab (ZLAB) Depreciation & Amortization (CF) (2018 - 2026) Analysis & Trends

Zai Lab has reported Depreciation & Amortization (CF) for 9 years, with the latest figure at $3.9 million in Q1 2026.

  • Quarterly Depreciation & Amortization (CF) rose 14.05% year-over-year to $3.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.5 million (up 25.96% YoY) and the FY2025 annual result came in at $15.0 million, up 26.6% from the prior year.
  • Depreciation & Amortization (CF) advanced to $3.9 million in Q1 2026 per ZLAB's latest filing, from $3.9 million in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $3.9 million in Q1 2026 and troughed at $1.9 million in Q2 2022.
  • A 5-year average of $2.8 million and a median of $2.9 million in 2024 frame the typical range for Depreciation & Amortization (CF).
  • The sharpest annual moves came in 2023 and 2024: Depreciation & Amortization (CF) dropped 13.84% in 2023, then soared 49.69% in 2024.
  • Over 5 years, Depreciation & Amortization (CF) stood at $2.1 million in 2022, then increased by 15.61% to $2.5 million in 2023, then grew by 23.3% to $3.0 million in 2024, then advanced by 29.16% to $3.9 million in 2025, then increased by 0.72% to $3.9 million in 2026.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $3.9 million, $3.9 million, and $3.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Vertex Pharmaceuticals 138.43 Bn 130.58 Bn 2.84 Bn 56.50 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 123.70 Mn
3 Argenx Se 63.34 Bn 58.15 Bn 1.37 Bn -
4 Moderna 57.98 Bn 52.85 Bn 52.00 Mn -
5 Revolution Medicines 43.98 Bn 43.98 Bn - -
6 BeOne Medicines 39.92 Bn 34.82 Bn 1.53 Bn 40.52 Mn
7 Alnylam Pharmaceuticals 35.42 Bn 32.11 Bn 992.69 Mn -
8 Royalty Pharma 28.42 Bn 27.58 Bn - -
9 Insmed 27.36 Bn 26.20 Bn 358.27 Mn -
10 Zai Lab 2.94 Bn 2.23 Bn 58.15 Mn 4.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.17 Mn
Mar 31, 2026 3.94 Mn
Dec 31, 2025 3.92 Mn
Sep 30, 2025 3.90 Mn
Jun 30, 2025 3.74 Mn
Mar 31, 2025 3.46 Mn
Dec 31, 2024 3.03 Mn
Sep 30, 2024 2.87 Mn
Jun 30, 2024 2.94 Mn
Mar 31, 2024 3.01 Mn
Dec 31, 2023 2.46 Mn
Sep 30, 2023 1.92 Mn
Jun 30, 2023 2.00 Mn
Mar 31, 2023 2.66 Mn
Dec 31, 2022 2.13 Mn
Sep 30, 2022 2.23 Mn
Jun 30, 2022 1.86 Mn
Mar 31, 2022 2.01 Mn
Dec 31, 2021 1.88 Mn
Sep 30, 2021 1.64 Mn